RU2305680C2 - Ненуклеозидные ингибиторы обратной транскриптазы, их применение, фармацевтическая композиция для ингибирования вич - Google Patents

Ненуклеозидные ингибиторы обратной транскриптазы, их применение, фармацевтическая композиция для ингибирования вич Download PDF

Info

Publication number
RU2305680C2
RU2305680C2 RU2005128832/04A RU2005128832A RU2305680C2 RU 2305680 C2 RU2305680 C2 RU 2305680C2 RU 2005128832/04 A RU2005128832/04 A RU 2005128832/04A RU 2005128832 A RU2005128832 A RU 2005128832A RU 2305680 C2 RU2305680 C2 RU 2305680C2
Authority
RU
Russia
Prior art keywords
alkyl
alkoxy
phenyl
optionally substituted
substituted
Prior art date
Application number
RU2005128832/04A
Other languages
English (en)
Russian (ru)
Other versions
RU2005128832A (ru
Inventor
Джеймс Патрик ДАНН (US)
Джеймс Патрик ДАНН
Джоан Хедер ХОГГ (US)
Джоан Хедер ХОГГ
Таранех МИРЗАДЕГАН (US)
Таранех МИРЗАДЕГАН
Стивен СВОЛОУ (US)
Стивен СВОЛОУ
Original Assignee
Ф.Хоффманн-Ля Рош Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ф.Хоффманн-Ля Рош Аг filed Critical Ф.Хоффманн-Ля Рош Аг
Publication of RU2005128832A publication Critical patent/RU2005128832A/ru
Application granted granted Critical
Publication of RU2305680C2 publication Critical patent/RU2305680C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
RU2005128832/04A 2003-02-18 2004-02-17 Ненуклеозидные ингибиторы обратной транскриптазы, их применение, фармацевтическая композиция для ингибирования вич RU2305680C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44797403P 2003-02-18 2003-02-18
US60/447,974 2003-02-18

Publications (2)

Publication Number Publication Date
RU2005128832A RU2005128832A (ru) 2006-04-27
RU2305680C2 true RU2305680C2 (ru) 2007-09-10

Family

ID=32908518

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2005128832/04A RU2305680C2 (ru) 2003-02-18 2004-02-17 Ненуклеозидные ингибиторы обратной транскриптазы, их применение, фармацевтическая композиция для ингибирования вич

Country Status (17)

Country Link
US (1) US7241794B2 (https=)
EP (1) EP1597235B1 (https=)
JP (1) JP4608480B2 (https=)
KR (1) KR100776093B1 (https=)
CN (1) CN100389109C (https=)
AR (1) AR043195A1 (https=)
AT (1) ATE370124T1 (https=)
BR (1) BRPI0407591A (https=)
CA (1) CA2515151C (https=)
CL (1) CL2004000270A1 (https=)
DE (1) DE602004008227T2 (https=)
ES (1) ES2291854T3 (https=)
MX (1) MXPA05008748A (https=)
PL (1) PL378556A1 (https=)
RU (1) RU2305680C2 (https=)
TW (1) TW200423930A (https=)
WO (1) WO2004074257A1 (https=)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4041153B2 (ja) * 2003-05-07 2008-01-30 ファイザー・プロダクツ・インク カンナビノイド受容体リガンドとその使用
US8022225B2 (en) 2004-08-04 2011-09-20 Taisho Pharmaceutical Co., Ltd Triazole derivative
UA87884C2 (uk) * 2004-12-03 2009-08-25 Мерк Энд Ко., Инк. Безводна кристалічна калієва сіль інгібітора віл-інтегрази
EP1988083B1 (en) 2006-02-03 2014-04-02 Taisho Pharmaceutical Co., Ltd. Triazole derivative
JP5218737B2 (ja) * 2006-02-06 2013-06-26 大正製薬株式会社 スフィンゴシン−１−リン酸結合阻害物質
CA2642308C (en) * 2006-02-14 2013-12-17 Ihara Chemical Industry Co., Ltd. Process for production of 5-alkoxy-4-hydroxymethylpyrazole compound
CL2007002105A1 (es) * 2006-07-21 2008-02-22 Hoffmann La Roche Compuestos derivados de 2-[3-(3-cianofenoxi)(fenoxi o fenilsulfanil)]-n-fenil acetamida, inhibidores de la transcriptasa inversa del vih; procedimiento de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar u
CA2658984C (en) 2006-08-16 2014-12-02 Joshua Kennedy-Smith Non-nucleoside reverse transcriptase inhibitors
BRPI0809617A2 (pt) 2007-03-29 2014-09-16 Hoffmann La Roche Inibidores não-nucleosídicos da transcriptase reversa
DK2177512T3 (da) 2007-08-01 2012-06-18 Taisho Pharmaceutical Co Ltd S1P1-bindingshæmmer
RU2495878C2 (ru) * 2007-12-21 2013-10-20 Ф.Хоффманн-Ля Рош Аг Гетероциклические антивирусные соединения
DE102008015033A1 (de) * 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituierte (Pyrazolyl-carbonyl)imidazolidinone und ihre Verwendung
SI2924034T1 (sl) * 2010-03-30 2017-05-31 Merck Canada Inc. Farmacevtski sestavek, ki obsega nenukleozidni inhibitor reverzne transkriptaze
CN103097357B (zh) 2010-07-15 2015-01-28 大日本住友制药株式会社 吡唑化合物
EP2508511A1 (en) * 2011-04-07 2012-10-10 Laboratoire Biodim Inhibitors of viral replication, their process of preparation and their therapeutical uses
WO2013134562A1 (en) 2012-03-09 2013-09-12 Inception 2, Inc. Triazolone compounds and uses thereof
CN104797255A (zh) 2012-06-20 2015-07-22 范德比尔特大学 作为mglur5受体变构调节剂的取代的双环烷氧基吡唑类似物
WO2013192343A1 (en) 2012-06-20 2013-12-27 Vanderbilt University Substituted bicyclic alkoxy pyrazole analogs as allosteric modulators of mglur5 receptors
JO3470B1 (ar) 2012-10-08 2020-07-05 Merck Sharp & Dohme مشتقات 5- فينوكسي-3h-بيريميدين-4-أون واستخدامها كمثبطات ناسخ عكسي ل hiv
AU2013363398B2 (en) 2012-12-20 2017-06-01 Tempest Therapeutics, Inc. Triazolone compounds and uses thereof
US9776976B2 (en) 2013-09-06 2017-10-03 Inception 2, Inc. Triazolone compounds and uses thereof
WO2015153304A1 (en) 2014-04-01 2015-10-08 Merck Sharp & Dohme Corp. Prodrugs of hiv reverse transcriptase inhibitors
EP3194386A2 (en) 2014-09-17 2017-07-26 Ironwood Pharmaceuticals, Inc. Sgc stimulators
US20170298055A1 (en) 2014-09-17 2017-10-19 Ironwood Pharmaceuticals, Inc. sGC STIMULATORS
CA2978066A1 (en) * 2015-03-19 2016-09-22 E I Du Pont De Nemours And Company Fungicidal pyrazoles
EP3478665A1 (en) * 2016-06-29 2019-05-08 Esteve Pharmaceuticals, S.A. Pyrazole derivatives having activity against pain
CN110818636A (zh) * 2019-11-29 2020-02-21 河北科技大学 一种化合物或其盐及其应用和合成方法
CN115677585B (zh) * 2022-10-31 2024-03-19 上海群力化工有限公司 一种甲醛吡唑衍生物的合成工艺

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999007698A1 (de) * 1997-08-11 1999-02-18 Bayer Aktiengesellschaft (hetero)aryloxypyrazole als herbizide
RU99109971A (ru) * 1996-10-14 2001-03-20 Байер Акциенгезелльшафт Новые гетероциклилметилзамещенные производные пиразола
WO2002004424A1 (en) * 2000-07-07 2002-01-17 Pfizer Limited Pyrazole derivatives
WO2002030907A1 (en) * 2000-10-10 2002-04-18 F. Hoffmann-La Roche Ag Pyrazole derivatives for the treatment of viral diseases
WO2002100853A1 (en) * 2001-06-04 2002-12-19 F. Hoffmann-La Roche Ag Pyrazole derivatives as hiv reverse transcriptase inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2157368C2 (ru) 1994-09-26 2000-10-10 Сионоги Энд Ко., Лтд. Производные имидазола и фармацевтическая композиция на их основе
US20030008841A1 (en) 2000-08-30 2003-01-09 Rene Devos Anti-HCV nucleoside derivatives
GB0028484D0 (en) 2000-11-22 2001-01-10 Hoffmann La Roche Imidazolone derivatives for the treatment of viral diseases
RS51166B (sr) * 2001-04-10 2010-10-31 Pfizer Inc. Derivati pirazola za tretiranje hiv

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU99109971A (ru) * 1996-10-14 2001-03-20 Байер Акциенгезелльшафт Новые гетероциклилметилзамещенные производные пиразола
WO1999007698A1 (de) * 1997-08-11 1999-02-18 Bayer Aktiengesellschaft (hetero)aryloxypyrazole als herbizide
WO2002004424A1 (en) * 2000-07-07 2002-01-17 Pfizer Limited Pyrazole derivatives
WO2002030907A1 (en) * 2000-10-10 2002-04-18 F. Hoffmann-La Roche Ag Pyrazole derivatives for the treatment of viral diseases
WO2002100853A1 (en) * 2001-06-04 2002-12-19 F. Hoffmann-La Roche Ag Pyrazole derivatives as hiv reverse transcriptase inhibitors

Also Published As

Publication number Publication date
KR20050105471A (ko) 2005-11-04
US7241794B2 (en) 2007-07-10
AU2004213134A1 (en) 2004-09-02
CN100389109C (zh) 2008-05-21
RU2005128832A (ru) 2006-04-27
AR043195A1 (es) 2005-07-20
CN1751028A (zh) 2006-03-22
KR100776093B1 (ko) 2007-11-15
DE602004008227D1 (de) 2007-09-27
DE602004008227T2 (de) 2008-05-15
CA2515151C (en) 2010-11-30
BRPI0407591A (pt) 2006-02-14
ATE370124T1 (de) 2007-09-15
WO2004074257A1 (en) 2004-09-02
MXPA05008748A (es) 2005-09-20
TW200423930A (en) 2004-11-16
EP1597235A1 (en) 2005-11-23
EP1597235B1 (en) 2007-08-15
ES2291854T3 (es) 2008-03-01
CA2515151A1 (en) 2004-09-02
CL2004000270A1 (es) 2005-02-04
PL378556A1 (pl) 2006-05-02
JP2006515339A (ja) 2006-05-25
JP4608480B2 (ja) 2011-01-12
US20040192666A1 (en) 2004-09-30

Similar Documents

Publication Publication Date Title
RU2305680C2 (ru) Ненуклеозидные ингибиторы обратной транскриптазы, их применение, фармацевтическая композиция для ингибирования вич
TWI235752B (en) Inhibitors of c-JUN N-terminal kinases (JNK) and other protein kinases
KR100569324B1 (ko) Ｈｉｖ 치료용 피라졸 유도체
US6750230B2 (en) Pyrazole derivatives
WO1999062885A1 (en) Substituted 1-(4-aminophenyl)pyrazoles and their use as anti-inflammatory agents
WO2006085685A1 (ja) ピラゾール化合物
US6933312B2 (en) Pyrazole derivatives
CA2505945A1 (en) Pyrazole derivatives useful as cox-i inhibitors
US7951956B2 (en) Benzoimidazole compound capable of inhibiting prostaglandin D synthetase
ES2207497T3 (es) 1,4-dihidroindeno(1,2-c)pirazoles sustituidos como inhibidores de tirosina quinasa.
EP1673355A1 (en) Substituted triazole derivatives as oxytocin antagonists
JP2004532276A (ja) Ｈｉｖ逆転写酵素阻害剤としてのピラゾール誘導体
ES2298616T3 (es) Derivados de pirazol.
US9249148B2 (en) Tris(hetero)arylpyrazoles and use thereof
JPH1149762A (ja) チアゾール化合物
US20050054707A1 (en) Pyrazole derivatives
US7157468B2 (en) Pyrazole derivatives
AU2004213134B2 (en) Non-nucleoside reverse transcriptase inhibitors
JP2006504803A (ja) ピラゾール誘導体
ES2305563T3 (es) Derivados de pirazol y su uso como agentes terapeuticos para enfermedades mediadas por el vih.
US7230025B2 (en) Pyrazole derivatives
WO2026033305A1 (en) Fused bicyclic heterocyclic derivatives as hdac inhibitors
JPWO2019188456A1 (ja) 新規抗腫瘍剤
MXPA00011920A (en) Substituted 1-(4-aminophenyl)pyrazoles and their use as anti-inflammatory agents